Newsroom

Media Inquiries

For general media inquiries or to request a logo/photo, please call 800-227-9597 Ex. 56044 or send a message using our:

Online inquiries form »

Learn more about us

Note: Credit “LexisNexis” for any publication of an image or video from one of these sites.

LexisNexis® Acquires Enclarity

September 11, 2013 — Third acquisition in a year as company strengthens its identity, fraud and clinical analytics to offer 360° view of health care providers

ATLANTA — LexisNexis® Risk Solutions today announced the acquisition of Enclarity, Inc. an industry-leading health care provider data and information solutions company.  The deal will enable LexisNexis to add Enclarity's health care provider data to its existing analytics platforms and workflows, and help customers contain health care costs and improve the quality of health care outcomes. The acquisition follows the transfer of clinical-analytics-focused MEDai into LexisNexis Risk Solutions from LexisNexis sister company Elsevier, Inc. in July 2013 and the fall 2012 purchase of EDIWatch, a provider of fraud, waste and abuse technology solutions.

With the acquisition of Enclarity, LexisNexis becomes a leader in health care provider data and provider identity transparency which helps:

  • Health care payers and providers manage provider files more efficiently and gain greater transparency into the identity of each provider;
  • Health care customers reduce fraud, waste and abuse by better assessing the risk associated with provider identities and quickly identifying hidden, complex and collusive activities; and
  • Consumers make more informed decisions by giving them transparency into the identity, practicing patterns and integrity of the providers in their health benefit programs.

"This acquisition demonstrates our continued commitment to helping health care organizations address cost-containment head-on by improving effectiveness and efficiencies, applying clinical analytics and reducing costs and offering greater identity transparency," said Lee Rivas, CEO Public Sector and Health Care.

Through these three acquisitions, LexisNexis now offers end-to-end health care solutions enabling cost containment by reducing exposure of fraud, waste and abuse through detection, recovery and prevention, along with improved clinical outcomes through identity management, predictive modeling and clinical analytics.

Click here for more information on the LexisNexis health care portfolio.

About LexisNexis Risk Solutions
LexisNexis Risk Solutions (www.lexisnexis.com/risk/) is a leader in providing essential information that helps customers across industries and government predict, assess and manage risk. Combining cutting-edge technology, unique data and advanced analytics, Risk Solutions provides products and services that address evolving client needs in the risk sector while upholding the highest standards of security and privacy. LexisNexis Risk Solutions is part of Reed Elsevier, a leading global provider of professional information solutions across a number of sectors.

Our health care solutions assist payers, providers and integrators with ensuring appropriate access to health care data and programs, enhancing disease management contact ratios, improving operational processes, and proactively combating fraud, waste and abuse across the continuum.

About Enclarity
Enclarity solves healthcare's provider information problem by compiling the largest, most accurate and current medical provider database. Nine of the 15 largest health insurance plans, four of the 10 largest preferred provider organizations, five of the top 15 pharmaceutical companies and the two largest medical device manufacturers count on Enclarity. Its solutions improve claims processing, provider directories, regulatory compliance and marketing optimization. For more information, visit www.enclarity.com.

Media Contacts
Regina Haas
LexisNexis Risk Solutions
Phone: +1.678.694.3569
regina.haas@lexisnexis.com

Paul Abrahams
Reed Elsevier
Phone: +44 (0)20 7166 5724
paul.abrahams@reedelsevier.com

Investor Relations
Colin Tennant
Reed Elsevier
Phone: +44 (0)207 166 5751
colin.tennant@reedelsevier.com

Back to Top
Solutions
Industries
Bookstore
Support & Training
Communities
Contact Us